Suchergebnisse - "Schmid, Peter"

PubPharm (22)

1

A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative)

enthalten in: Future oncology (London, England) | 2024

von Rugo, H. | Bardia, A. | Marmé, F. | +4

2

Emerging strategies for TNBC with early clinical data : new chemoimmunotherapy strategies

enthalten in: Breast cancer research and treatment | 2022

von Hall, P. | Schmid, P.

3

Immunotherapy for early triple negative breast cancer : research agenda for the next decade

enthalten in: NPJ breast cancer | 2022

von Tarantino, P. | Corti, C. | Schmid, P. | +7

4

Emerging drugs for the treatment of triple-negative breast cancer : a focus on phase II immunotherapy trials

enthalten in: Expert opinion on emerging drugs | 2021

von Hall, P. | Schmid, P.

5

A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction

enthalten in: Breast (Edinburgh, Scotland) | 2021

von Varghese, J. | Gohari, S. | Rizki, H. | +5

6

Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer : A Meta-Analysis

enthalten in: Cancer research | 2020

von Huang, M. | O'Shaughnessy, J. | Zhao, J. | +15

7

Evaluation of Pathologic Complete Response as a Surrogate for Long-Term Survival Outcomes in Triple-Negative Breast Cancer

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2020

von Huang, M. | O'Shaughnessy, J. | Zhao, J. | +14

8

Enhancing global access to cancer medicines

enthalten in: CA: a cancer journal for clinicians | 2020

von Cortes, J. | Perez-García, J. | Llombart-Cussac, A. | +13

9

The emerging world of breast cancer immunotherapy

enthalten in: Breast (Edinburgh, Scotland) | 2018

von Nathan, M. | Schmid, P.

10

Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer

enthalten in: Current cancer drug targets | 2018

von O'Leary, K. | Shia, A. | Schmid, P.